Antibody Engineering: Foundations & Therapeutic Applications

Dive into the fascinating world of antibodies—the body’s natural defense molecules. This lecture explores their discovery, elegant Y-shaped structure, antigen-binding capabilities, and functional classes (IgG, IgM, etc.). By understanding the molecular foundation, you’ll be better equipped to grasp their immense potential in therapy and diagnostics.

Learn how monoclonal antibodies reshaped biotechnology. This session introduces the hybridoma technique that made it possible to produce highly specific, uniform antibodies at scale. Discover how monoclonals are used in cancer, autoimmune diseases, and lab research—and why they remain central to today’s medical breakthroughs.

Explore how scientists select the best-performing antibodies using phage, yeast, and ribosome display. These revolutionary platforms allow rapid, targeted screening from vast libraries. Understand how these systems mimic evolution in a test tube—accelerating the development of antibodies with high affinity and therapeutic value.

This lecture unveils how transgenic animals like the XenoMouse produce fully human antibodies with minimal side effects. Learn the genetic strategies behind these innovations and why they play a major role in generating safe, effective biologics used in real-world clinical therapies today.

See how antibodies work beyond the lab—treating cancers, diagnosing infections, and enabling cutting-edge research. From immunoassays to PET imaging, this lecture covers how antibodies are used across science and medicine, making them indispensable tools in nearly every biomedical field.

Bispecific antibodies can bind to two different targets at once, making them game-changers in cancer therapy and immune modulation. In this lecture, discover how they work, why they’re powerful, and real clinical examples like Blinatumomab that show their life-saving potential.

Unlock the next level of targeted therapy. ADCs combine the precision of antibodies with potent anti-cancer drugs. This lecture covers their modular design (antibody + linker + toxin), FDA-approved examples, and how they selectively destroy tumor cells while sparing healthy ones.

Learn how CAR-T therapy uses engineered antibodies to guide T cells to cancer. This innovative immunotherapy has revolutionized treatment for leukemia and lymphoma. We’ll break down CAR design, clinical successes, and the future of this personalized cancer approach—all explained in simple terms.

Not all antibodies are created equal. This lecture explores how to improve their stability, half-life, and specificity using glycoengineering, Fc-modifications, and in silico design. These enhancements are crucial to making antibody drugs safer, longer-lasting, and more effective.